Search for: "In re Cipro Cases" Results 21 - 40 of 78
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2009, 12:10 pm
The amici also urge the Supreme Court that the Cipro case is the appropriate vehicle to resolve the important questions presented. [read post]
9 Sep 2010, 12:20 pm by FDABlog HPM
Barr Labs., Inc., (In re Tamoxifen Citrate Antitrust Litig.), 466 F.3d 187 (2d Cir. 2005), compelled it to do so: “Since Tamoxifen rejected antitrust challenges to reverse payments as a matter of law, we are bound to review the Cipro court’s rulings under the standard adopted in Tamoxifen. [read post]
20 Aug 2013, 5:00 am by Kimberly A. Kralowec
Valencia Holding Co., LLC, 201 Cal.App.4th 74 (2011) In re Cipro Cases I & II, no. [read post]
17 Dec 2009, 7:02 am by Matt C. Bailey
(citing In re Cipro Cases I & II, 121 Cal.App.4th 402, 418 (2004).While each of these defects may have been resolved by redefining the class [Hicks v. [read post]
28 Feb 2011, 8:27 am by Antitrust Today
Bayer AG (In re Ciprofloxacin Hydrochloride Antitrust Litig.), 05-2851-cv(L) (2d Cir. 2010) (“Cipro”). [read post]
15 Mar 2011, 11:40 am by Phil
Bayer AG (In re Ciprofloxacin Hydrochloride Antitrust Litig.), 05-2851-cv(L) (2d Cir. 2010) ("Cipro"). [read post]
5 May 2010, 2:49 pm
(In re Tamoxifen Citrate Antitrust Litig.), 2006-2 Trade Cases ¶75,382. [read post]
31 Oct 2008, 8:30 pm
  In re Ciprofloxacin Hydrochloride Antitrust Litigation (08-1097). [read post]
20 Oct 2015, 3:34 am by Denis Stearns
Cipro is often prescribed to people who travel internationally, in case they develop diarrhea while out of the United States. [read post]
17 Feb 2012, 4:19 pm by The Complex Litigator
  Notable results include: On a petition for review, review was granted in In re Cipro Cases I & II. [read post]
2 May 2011, 8:13 am by PunditMom
   And I’ll be scoping out the shopping carts of others to see if they’re doing the same. [read post]
13 Sep 2012, 4:26 pm by Brad Pauley
Supreme Court’s Resolution of Related Case In re Cipro Cases I & II, S198616—Briefing Stayed—September 12, 2012 The question presented is whether an action under the Cartwright Antitrust Act (Bus. [read post]
24 Oct 2008, 7:49 pm
In this case, Barr Laboratories sought permission to market a generic version of Cipro before the expiration of Bayer's patent on Cipro's active ingredient. [read post]
9 Feb 2018, 11:56 am by Dennis Crouch
This decision reverses the court’s position from In re Ciprofloxacin Hydrochloride (Cipro) Antitrust Litigation, 544 F.3d 1323 (Fed. [read post]
18 Feb 2012, 8:27 pm by Brad Pauley
In re Cipro Cases I & II, S198616—Review Granted—February 15, 2012  The question presented is whether a suit may be brought under the Cartwright Antitrust Act to challenge “reverse exclusionary payments” made by pharmaceutical manufacturers to settle patent litigation with generic drug producers and prolong the life of the patents in question. [read post]